The First Affiliated Hospital Of Chengdu Medical College
🇨🇳China
Clinical Trials
4
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)No trials found
News
HSP60 Expression Levels Emerge as Critical Prognostic Marker in Ovarian Cancer Study
A comprehensive study of 260 ovarian cancer patients reveals that high HSP60 expression correlates significantly with advanced disease stages, larger tumors, and increased lymph node metastasis.